Tarsus Pharmaceuticals (TARS) P/E (2020 - 2026)
Tarsus Pharmaceuticals (TARS) P/E from Dec 31, 2020 to Jul 21, 2026. The TTM Tarsus Pharmaceuticals (TARS) P/E is -50.36. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Tarsus Pharmaceuticals (TARS)
| Year | P/E | Change |
|---|---|---|
| 2026 | -50.36 | -3.24% |
| 2025 | -52.05 | +185.55% |
| 2024 | -18.23 | +236.06% |
| 2023 | -5.42 | +1.88% |
| 2022 | -5.32 | -84.32% |
| 2021 | -33.96 | -53.63% |
| 2020 | -73.23 | N/A |
Comparison Tarsus Pharmaceuticals (TARS) P/E with competitors
Tarsus Pharmaceuticals (TARS) P/E is -50.36.